Financhill
Back

Diebold Nixdorf, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
84

DBD
Diebold Nixdorf, Inc.

Last Price:
$67.63
Seasonality Move:
11.65%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.60
Seasonality Move:
10.35%
Buy
84
Diebold Nixdorf, Inc. (DBD) is a Buy

Is Diebold Nixdorf, Inc. a Buy, Sell or Hold?

  • The current Diebold Nixdorf, Inc. [DBD] share price is $67.65. The Score for DBD is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • DBD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

DBD Stock Price Chart

What is Diebold Nixdorf, Inc.'s stock price today?

  • The Diebold Nixdorf, Inc. share price today is $67.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBD is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

DBD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.51 Buy
Relative Strength Index (14 RSI): 65.38 Buy
Chaikin Money Flow: 1359 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.69 - 66.31) Buy
Bollinger Bands (100): (56.97 - 63.45) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

DBD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.01 Buy
20-day SMA: 64.35 Buy
50-day SMA: 61.14 Buy
200-day SMA: 54.05 Buy
8-day EMA: 66.03 Buy
20-day EMA: 64.59 Buy
50-day EMA: 62.28 Buy
200-day EMA: 55.47 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Diebold Nixdorf, Inc. Earnings Growth & DBD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.89 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Diebold Nixdorf, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):